California Institute for Regenerative Medicine (CIRM)
@cirmnews.bsky.social
CIRM's mission is to accelerate world-class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. Visit our website at cirm.ca.gov.
The official CIRM account.
The official CIRM account.
Epilepsy affects millions, with 1/3 unresponsive to meds. CIRM funds early- to clinical-stage research for new stem cell therapies at UCSF & Neurona Therapeutics, offering hope for a better life. Learn more: https://bit.ly/3LWmYZz
November 24, 2025 at 9:22 PM
Epilepsy affects millions, with 1/3 unresponsive to meds. CIRM funds early- to clinical-stage research for new stem cell therapies at UCSF & Neurona Therapeutics, offering hope for a better life. Learn more: https://bit.ly/3LWmYZz
Access to clinical trials shouldn’t depend on where you live. CIRM is investing $27M to establish three Community Care Centers of Excellence in South LA, the Inland Empire & Desert Region, & the Central Valley—bringing stem cell & gene therapy trials closer to home. For more: https://bit.ly/3Wwl4Rq
October 30, 2025 at 5:45 PM
Access to clinical trials shouldn’t depend on where you live. CIRM is investing $27M to establish three Community Care Centers of Excellence in South LA, the Inland Empire & Desert Region, & the Central Valley—bringing stem cell & gene therapy trials closer to home. For more: https://bit.ly/3Wwl4Rq
Yael Wyte has spent 20+ years advocating for people with #Alzheimers. Now, as a CIRM Board member, she’s helping advance #RegenerativeMedicine with compassion and purpose.
Read her full story: https://bit.ly/48HhD1B
Read her full story: https://bit.ly/48HhD1B
October 22, 2025 at 3:30 PM
Yael Wyte has spent 20+ years advocating for people with #Alzheimers. Now, as a CIRM Board member, she’s helping advance #RegenerativeMedicine with compassion and purpose.
Read her full story: https://bit.ly/48HhD1B
Read her full story: https://bit.ly/48HhD1B
CIRM’s 2025 Annual Report, Looking Forward: Advancing California’s Scientific Vision, is now available. It highlights #ScientificProgress, patient stories, and efforts to expand access to #RegenerativeMedicine across California.
Explore it here: https://adobe.ly/42FSVed
Explore it here: https://adobe.ly/42FSVed
October 16, 2025 at 3:30 PM
CIRM’s 2025 Annual Report, Looking Forward: Advancing California’s Scientific Vision, is now available. It highlights #ScientificProgress, patient stories, and efforts to expand access to #RegenerativeMedicine across California.
Explore it here: https://adobe.ly/42FSVed
Explore it here: https://adobe.ly/42FSVed
Behind every breakthrough is years of science. Kim Barrett, PhD, says @ucdavishealth.bsky.social CuRe Trial for spina bifida was possible thanks to early studies funded by CIRM’s Discovery program. Investing across the pipeline turns discoveries into therapies.
Learn more: https://bit.ly/3W2nUNF
Learn more: https://bit.ly/3W2nUNF
October 1, 2025 at 3:30 PM
Behind every breakthrough is years of science. Kim Barrett, PhD, says @ucdavishealth.bsky.social CuRe Trial for spina bifida was possible thanks to early studies funded by CIRM’s Discovery program. Investing across the pipeline turns discoveries into therapies.
Learn more: https://bit.ly/3W2nUNF
Learn more: https://bit.ly/3W2nUNF
Adrienne Shapiro, a 4th-generation mother of children with sickle cell disease, has been a tireless advocate for stem cell research and a powerful patient voice at CIRM. Her efforts helped advance a groundbreaking trial at @uclastemcell.bsky.social.
Read her story: https://bit.ly/3VAQfKY
Read her story: https://bit.ly/3VAQfKY
September 26, 2025 at 3:30 PM
Adrienne Shapiro, a 4th-generation mother of children with sickle cell disease, has been a tireless advocate for stem cell research and a powerful patient voice at CIRM. Her efforts helped advance a groundbreaking trial at @uclastemcell.bsky.social.
Read her story: https://bit.ly/3VAQfKY
Read her story: https://bit.ly/3VAQfKY
“Discovery research is critical for uncovering novel disease targets and biomarkers that we can translate into therapies for clinical use,” said Kelly Shepard, PhD, Director of Discovery & Education programs at CIRM.
Read the full announcement: https://bit.ly/4gDLREC
Read the full announcement: https://bit.ly/4gDLREC
September 25, 2025 at 11:12 PM
“Discovery research is critical for uncovering novel disease targets and biomarkers that we can translate into therapies for clinical use,” said Kelly Shepard, PhD, Director of Discovery & Education programs at CIRM.
Read the full announcement: https://bit.ly/4gDLREC
Read the full announcement: https://bit.ly/4gDLREC
Evie Junior, born with #SickleCellDisease, participated in a CIRM-funded clinical trial at @uclastemcell.bsky.social, using his own modified stem cells. He’s now free from pain crises and meds.
This #SickleCellAwarenessMonth, we highlight the promise of curative therapies. https://bit.ly/47YO3o6
This #SickleCellAwarenessMonth, we highlight the promise of curative therapies. https://bit.ly/47YO3o6
September 24, 2025 at 3:30 PM
Evie Junior, born with #SickleCellDisease, participated in a CIRM-funded clinical trial at @uclastemcell.bsky.social, using his own modified stem cells. He’s now free from pain crises and meds.
This #SickleCellAwarenessMonth, we highlight the promise of curative therapies. https://bit.ly/47YO3o6
This #SickleCellAwarenessMonth, we highlight the promise of curative therapies. https://bit.ly/47YO3o6
Babies with spina bifida are growing into walking, healthy toddlers thanks to a CIRM-funded trial at @ucdavishealth.bsky.social. Board member Kim Barrett shares why this work brings real hope.
Read the full story: https://bit.ly/3W2nUNF
Read the full story: https://bit.ly/3W2nUNF
September 23, 2025 at 4:56 PM
Babies with spina bifida are growing into walking, healthy toddlers thanks to a CIRM-funded trial at @ucdavishealth.bsky.social. Board member Kim Barrett shares why this work brings real hope.
Read the full story: https://bit.ly/3W2nUNF
Read the full story: https://bit.ly/3W2nUNF
Maya Singh, a CIRM COMPASS trainee from @ucberkeleyofficial.bsky.social, helped advance #CancerResearch and gained key skills for med school. Now at Tuoro University California, she credits the COMPASS program for shaping her path.
blog.cirm.ca.gov/2025/08/27/c...
blog.cirm.ca.gov/2025/08/27/c...
September 9, 2025 at 4:42 PM
Maya Singh, a CIRM COMPASS trainee from @ucberkeleyofficial.bsky.social, helped advance #CancerResearch and gained key skills for med school. Now at Tuoro University California, she credits the COMPASS program for shaping her path.
blog.cirm.ca.gov/2025/08/27/c...
blog.cirm.ca.gov/2025/08/27/c...
Thank you to all the incredible trainees, program directors, patient advocates, and inspiring speakers who joined us for the 2025 #CIRMTraineeConference!
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
July 30, 2025 at 8:13 PM
Thank you to all the incredible trainees, program directors, patient advocates, and inspiring speakers who joined us for the 2025 #CIRMTraineeConference!
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
It’s great to hear about the various career paths in the #RegenerativeMedicine field—from R&D and lab work to policy and #SciComms. Thank you to our panelists for sharing their experiences and insights. #CIRMTraineeConference
July 28, 2025 at 5:26 PM
It’s great to hear about the various career paths in the #RegenerativeMedicine field—from R&D and lab work to policy and #SciComms. Thank you to our panelists for sharing their experiences and insights. #CIRMTraineeConference
Millions live with painful osteoarthritis worldwide. A CIRM-funded clinical trial by Genascence reported positive early results using a gene therapy approach, demonstrating safety and sustained efficacy at 12 months.
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
July 8, 2025 at 7:28 PM
Millions live with painful osteoarthritis worldwide. A CIRM-funded clinical trial by Genascence reported positive early results using a gene therapy approach, demonstrating safety and sustained efficacy at 12 months.
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
Backed by a $14 million CIRM award, Neurona Therapeutics is advancing a stem cell therapy that could transform epilepsy treatment without surgery or tissue damage. Learn more on our blog: blog.cirm.ca.gov/2025/06/20/n...
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
June 20, 2025 at 9:07 PM
Backed by a $14 million CIRM award, Neurona Therapeutics is advancing a stem cell therapy that could transform epilepsy treatment without surgery or tissue damage. Learn more on our blog: blog.cirm.ca.gov/2025/06/20/n...
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
🚨 REMINDER: Prospective DISC4 applicants, the Pre-Submission Form deadline is June 16 at 2 PM.
The DISC4 Awards support large, cross-disciplinary teams working on innovative ways to understand and treat human disease. Learn more at www.cirm.ca.gov/disc4/.
The DISC4 Awards support large, cross-disciplinary teams working on innovative ways to understand and treat human disease. Learn more at www.cirm.ca.gov/disc4/.
June 12, 2025 at 8:13 PM
🚨 REMINDER: Prospective DISC4 applicants, the Pre-Submission Form deadline is June 16 at 2 PM.
The DISC4 Awards support large, cross-disciplinary teams working on innovative ways to understand and treat human disease. Learn more at www.cirm.ca.gov/disc4/.
The DISC4 Awards support large, cross-disciplinary teams working on innovative ways to understand and treat human disease. Learn more at www.cirm.ca.gov/disc4/.
🚨 REMINDER: Preclinical Development (PDEV) Pre-submission forms are due June 12.
www.cirm.ca.gov/preclinical/
www.cirm.ca.gov/preclinical/
June 11, 2025 at 9:15 PM
🚨 REMINDER: Preclinical Development (PDEV) Pre-submission forms are due June 12.
www.cirm.ca.gov/preclinical/
www.cirm.ca.gov/preclinical/
CIRM’s Clinical Trial (CLIN2) Awards accelerate the development of regenerative medicine therapies for serious unmet medical needs. Our goal is to help these therapies progress toward FDA approval, improving patient care in California. Learn more at www.cirm.ca.gov/clinical/
June 5, 2025 at 7:48 PM
CIRM’s Clinical Trial (CLIN2) Awards accelerate the development of regenerative medicine therapies for serious unmet medical needs. Our goal is to help these therapies progress toward FDA approval, improving patient care in California. Learn more at www.cirm.ca.gov/clinical/
The Preclinical Development (PDEV) Awards accelerate the development of stem cell and genetic therapies. This funding supports preclinical work, from candidate optimization to FDA IND clearance, helping researchers bring treatments to patients. Learn more: www.cirm.ca.gov/preclinical/
May 28, 2025 at 10:30 PM
The Preclinical Development (PDEV) Awards accelerate the development of stem cell and genetic therapies. This funding supports preclinical work, from candidate optimization to FDA IND clearance, helping researchers bring treatments to patients. Learn more: www.cirm.ca.gov/preclinical/
CIRM is excited to announce that we have launched our new funding programs: the DISC4 (for multidisciplinary, collaborative basic #research), #Preclinical Development (PDEV), and #ClinicalTrial (CLIN2) Awards!
Learn more about our funding programs on our website at www.cirm.ca.gov/researchers/...
Learn more about our funding programs on our website at www.cirm.ca.gov/researchers/...
May 16, 2025 at 4:57 PM
CIRM is excited to announce that we have launched our new funding programs: the DISC4 (for multidisciplinary, collaborative basic #research), #Preclinical Development (PDEV), and #ClinicalTrial (CLIN2) Awards!
Learn more about our funding programs on our website at www.cirm.ca.gov/researchers/...
Learn more about our funding programs on our website at www.cirm.ca.gov/researchers/...
CIRM is officially on BlueSky 🦋
The California Institute for Regenerative Medicine (CIRM) is expanding its reach to BlueSky to share the latest developments in California stem cell and gene therapy research initiatives. [1/3]
The California Institute for Regenerative Medicine (CIRM) is expanding its reach to BlueSky to share the latest developments in California stem cell and gene therapy research initiatives. [1/3]
May 14, 2025 at 4:22 PM
CIRM is officially on BlueSky 🦋
The California Institute for Regenerative Medicine (CIRM) is expanding its reach to BlueSky to share the latest developments in California stem cell and gene therapy research initiatives. [1/3]
The California Institute for Regenerative Medicine (CIRM) is expanding its reach to BlueSky to share the latest developments in California stem cell and gene therapy research initiatives. [1/3]